Philip Scheltens

PROF.DR.

20022019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal

Alzheimer's Disease Neuroimaging Initiative, 2019, In : Neurology. 92, 23, p. e2699-e2705

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

AMYPAD Diagnostic and Patient Management Study: Rationale and design

Frisoni, G. B., Barkhof, F., Altomare, D., Berkhof, J., Boccardi, M., Canzoneri, E., Collij, L., Drzezga, A., Farrar, G., Garibotto, V., Gismondi, R., Gispert, J-D., Jessen, F., Kivipelto, M., Lopes Alves, I., Molinuevo, J-L., Nordberg, A., Payoux, P., Ritchie, C., Savicheva, I. & 8 othersScheltens, P., Schmidt, M. E., Schott, J., Stephens, A., van Berckel, B., Vellas, B., Walker, Z. & Raffa, N., Mar 2019, In : Alzheimers & Dementia. 15, 3, p. 388-399

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Activities 2010 2017

  • 7 Membership of board
  • 7 Membership of council
  • 5 Membership of committee

AC Immune SA (External organisation)

Philip Scheltens (Chair)
2017 → …

Activity: MembershipMembership of council

Toyama Pharma (External organisation)

Philip Scheltens (Chair)
2017 → …

Activity: MembershipMembership of council

Biogen Inc., Cambridge, Massachusetts 02142, USA. (External organisation)

Philip Scheltens (Chair)
2017 → …

Activity: MembershipMembership of council

Translational Neuroscience Network Conference 2017 (Event)

Jeroen Hoozemans (Chair), MM Schoonheim (Chair), MMM Wilhelmus (Chair), P Scheltens (Chair), AB Brussaard (Chair)
12 Oct 2017

Activity: MembershipMembership of board

EIP Pharma LLC (External organisation)

Philip Scheltens (Chair)
2016 → …

Activity: MembershipMembership of council